M E Miettinen1, L Kinnunen2, V Harjutsalo1,3,4,5, K Aimonen6, H-M Surcel7, C Lamberg-Allardt8, J Tuomilehto1,9,10,11,12. 1. Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland. 2. Genomics and Biomarkers Unit, National Institute for Health and Welfare, Helsinki, Finland. 3. Folkhälsan Institute of Genetics, Folkhälsan Research Center, University of Helsinki, Helsinki, Finland. 4. Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. 5. Research Program Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland. 6. Finnish Institute of Occupational Health, Helsinki, Finland. 7. Impact Assessment Unit, National Institute for Health and Welfare, Oulu, Finland. 8. Department of Food and Environmental Sciences, University of Helsinki, Helsinki, Finland. 9. Center for Vascular Prevention, Danube-University Krems, Krems, Austria. 10. South Ostrobothnia Central Hospital, Seinäjoki, Finland. 11. Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia. 12. Dasman Diabetes Institute, Dasman, Kuwait.
Abstract
BACKGROUND/ OBJECTIVES: The human leukocyte antigen (HLA) gene region associates with the risk for several autoimmune diseases, including type 1 diabetes. An association between vitamin D deficiency and several autoimmune diseases has been suggested. We tested the association between serum 25-hydroxyvitamin D (25OHD) concentrations and HLA alleles in pregnant Finnish women. SUBJECTS/ METHODS: HLA-B (n=395), HLA-DRB1 (n=501) and HLA-DQB1 (n=475) alleles were genotyped in pregnant women (mothers of children who later developed type 1 diabetes and mothers of non-diabetic children). HLA-B alleles were divided into supertypes that share similar peptide-binding specificity. Serum 25OHD concentration had been previously measured in these women from sera collected during the first trimester of pregnancy. Multiple testing was controlled for using the false discovery rate method. RESULTS: An association was found between 25OHD concentration and HLA-B44 supertype (P=0.009); women with HLA-B44 supertype (B*18, B*37, B*40 and B*44 alleles) had lower 25OHD concentrations. No association was found between HLA-DRB1 or -DQB1 alleles and 25OHD concentration. CONCLUSIONS: In this study we found for the first time an association between HLA genetic polymorphisms and 25OHD concentration. In future studies, the mechanistic background of this association and the role of vitamin D in the regulation of HLA gene expression should be investigated.
BACKGROUND/ OBJECTIVES: The human leukocyte antigen (HLA) gene region associates with the risk for several autoimmune diseases, including type 1 diabetes. An association between vitamin Ddeficiency and several autoimmune diseases has been suggested. We tested the association between serum 25-hydroxyvitamin D (25OHD) concentrations and HLA alleles in pregnant Finnish women. SUBJECTS/ METHODS:HLA-B (n=395), HLA-DRB1 (n=501) and HLA-DQB1 (n=475) alleles were genotyped in pregnant women (mothers of children who later developed type 1 diabetes and mothers of non-diabeticchildren). HLA-B alleles were divided into supertypes that share similar peptide-binding specificity. Serum 25OHD concentration had been previously measured in these women from sera collected during the first trimester of pregnancy. Multiple testing was controlled for using the false discovery rate method. RESULTS: An association was found between 25OHD concentration and HLA-B44 supertype (P=0.009); women with HLA-B44 supertype (B*18, B*37, B*40 and B*44 alleles) had lower 25OHD concentrations. No association was found between HLA-DRB1 or -DQB1 alleles and 25OHD concentration. CONCLUSIONS: In this study we found for the first time an association between HLA genetic polymorphisms and 25OHD concentration. In future studies, the mechanistic background of this association and the role of vitamin D in the regulation of HLA gene expression should be investigated.
Authors: M E Miettinen; L Reinert; L Kinnunen; V Harjutsalo; P Koskela; H-M Surcel; C Lamberg-Allardt; J Tuomilehto Journal: Diabetologia Date: 2012-01-20 Impact factor: 10.122
Authors: Maija E Miettinen; Melissa C Smart; Leena Kinnunen; Christopher Mathews; Valma Harjutsalo; Heljä-Marja Surcel; Christel Lamberg-Allardt; Jaakko Tuomilehto; Graham A Hitman Journal: Diabetologia Date: 2015-06-26 Impact factor: 10.122
Authors: Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight Journal: PLoS Genet Date: 2009-02-06 Impact factor: 5.917
Authors: Stefania Lenna; Shervin Assassi; G Alessandra Farina; Julio C Mantero; Raffaella Scorza; Robert Lafyatis; Harrison W Farber; Maria Trojanowska Journal: Arthritis Res Ther Date: 2015-12-16 Impact factor: 5.156
Authors: Marjaana Mäkinen; Eliisa Löyttyniemi; Maarit Koskinen; Mari Vähä-Mäkilä; Heli Siljander; Mirja Nurmio; Juha Mykkänen; Suvi M Virtanen; Olli Simell; Heikki Hyöty; Jorma Ilonen; Mikael Knip; Riitta Veijola; Jorma Toppari Journal: J Clin Endocrinol Metab Date: 2019-06-01 Impact factor: 5.958
Authors: Anna U Kraus; Marissa Penna-Martinez; Firouzeh Shoghi; Gesine Meyer; Klaus Badenhoop Journal: Front Immunol Date: 2020-12-07 Impact factor: 7.561